Department of Bioethics, National Institutes of Health, Bethesda, Maryland.
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; and.
Pediatrics. 2021 Mar;147(3). doi: 10.1542/peds.2020-040717. Epub 2020 Dec 17.
It is widely agreed that an effective response to the coronavirus disease 2019 pandemic needs to include a vaccine that is safe and effective for minors. However, many current vaccine trials have no plans for when to enroll minors. Others have recently proposed enrolling minors as young as 12 years old. This lack of a systematic approach raises 2 concerns. Waiting too long to enroll minors could unjustly deny minors and their families the benefits of a vaccine and has the potential to delay an effective response to the pandemic by a year or longer. At the same time, enrolling minors too soon runs the risk of exposing them to excessive risks. With these concerns in mind, in the present article, we propose recommendations for when and how to enroll minors in vaccine trials for the coronavirus disease 2019.
人们普遍认为,有效应对 2019 年冠状病毒病大流行需要包括一种对未成年人安全有效的疫苗。然而,目前许多疫苗试验都没有计划何时招募未成年人。其他试验最近则提议招募年龄低至 12 岁的未成年人。这种缺乏系统方法的做法引发了两个担忧。等待太久招募未成年人可能会不公正地剥夺未成年人及其家庭接种疫苗的益处,并有可能使应对大流行的有效措施延迟一年或更长时间。与此同时,过早招募未成年人有可能使他们面临过度风险。考虑到这些担忧,在本文中,我们提出了关于何时以及如何招募未成年人参加 2019 年冠状病毒病疫苗试验的建议。